Nov 8, 2021 Alcon has entered into an agreement to acquire Ivantis in a $475,000,000 deal. Alcon based at Geneva, Geneve, Switzerland. “Our mission is […]
Series A – Beacon Biosignals
On Nov 8, 2021 Beacon Biosignals closed a Series A round and raised $27,000,000 from Andrew Beck, Casdin Capital, General Catalyst, featuring lead investors General […]
Series C – Wellinks
On Nov 3, 2021 Wellinks closed a Series C round and raised $25,000,000 from Benslie Investment Group, Connecticut Innovations, HighCape Partners, Morningside Ventures, Stonehenge Capital, […]
Venture Round – Illumigyn
On Nov 3, 2021 Illumigyn closed a Venture – Series Unknown round and raised $33,000,000 from Ubicom Holdings, Yozma Group, featuring lead investors Ubicom Holdings, […]
Series B – Biolinq
On Nov 2, 2021 Biolinq closed a Series B round and raised $100,000,000 from Able Partners, Aphelion Capital, Ascensia Diabetes Care, AXA Investment Managers, Cirrus […]
Series A – Aktiia
On Nov 2, 2021 Aktiia closed a Series A round and raised $17,500,000 from 415 CAPITAL, Draper Esprit, Redalpine, Translink Capital, Verve Ventures, featuring lead […]
Series B – Biolinq
On Nov 2, 2021 Biolinq closed a Series B round and raised $100,000,000 from Able Partners, Aphelion Capital, Ascensia Diabetes Care, AXA Investment Managers, Cirrus […]
Series B – New View Surgical
On Nov 2, 2021 New View Surgical closed a Series B round and raised $9,000,000 from Ariel Savannah Angel Partners, Charleston Angel Partners, Corza Medical, […]
Series B – Violet Defense
On Nov 2, 2021 Violet Defense closed a Series B round and raised $20,000,000 from Katalyst Securities, Kirenaga Partners, featuring lead investors Katalyst Securities, Kirenaga […]
Seed Round – Swiftsure Innovations
On Nov 1, 2021 Swiftsure Innovations closed a Seed round and raised $1,050,000 from Killick Capital, Pelorus Venture Capital, Pluto Investments, Sandpiper Ventures, Threshold Impact, […]
